Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Harrington Institute
National Institutes of Health
Stanford Child Health Research Institute
Stanford SPARK
Child Health Research Institute and the Stanford NIH-NCATS-CTSA
JDRF
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference26 articles.
1. Bollyky PL, Falk BA, Long SA et al (2009) CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 183(4):2232–2241. https://doi.org/10.4049/jimmunol.0900191
2. Bayer AL, Yu A, Malek TR (2007) Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J Immunol 178(7):4062–4071. https://doi.org/10.4049/jimmunol.178.7.4062
3. Rosenzwajg M, Churlaud G, Mallone R et al (2015) Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. J Autoimmun 58:48–58. https://doi.org/10.1016/j.jaut.2015.01.001
4. Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA (1985) In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol 134(1):157–166
5. Cheever MA, Thompson JA, Kern DE, Greenberg PD (1985) Interleukin 2 (IL 2) administered in vivo: Influence of IL 2 route and timing on T cell growth. J Immunol 134:3895–3900 https://www.jimmunol.org/content/134/6/3895
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献